Inventor · disambiguated record
Keiji Hemmi
Also filed as: HEMMI KEIJI · KAMIYA TAKASHI · TERAJI TSUTOMU
51 granted patents·3 pending applications·838 citations·filing 1974–2003
98Inventor score
Files withFUJISAWA PHARMACEUTICAL CO48FUISAWA PHARMACEUTICAL COMPANY1HASHIMOTO MASASHI1TAKEDA CHEMICAL INDUSTRIES LTD1UJISAWA PHARMACEUTICAL CO LTD1
Top patents by PatentIndex Score
54 records- 0197US4963530ARenin inhibitor peptide compounds, a process for the preparation thereof and pharmaceutical composition comprising the sameFUJISAWA PHARMACEUTICAL CO·Filed 1988·Granted Oct 16, 1990·167 cites·10 claims
- 0296US4940709APiperazine compound as PAF-antagonistFUJISAWA PHARMACEUTICAL CO·Filed 1987·Granted Jul 10, 1990·67 cites·1 claims
- 0395US4806538APiperazine compound as PAF-antagonistFUJISAWA PHARMACEUTICAL CO·Filed 1987·Granted Feb 21, 1989·52 cites·16 claims
- 0493US4207234A4-Unsubstituted azetidinone derivatives and process for preparation thereofFUJISAWA PHARMACEUTICAL CO·Filed 1977·Granted Jun 10, 1980·29 cites·4 claims
- 0592US4206156AHydroxyaminohydrocarbonphosphonic acidsFUJISAWA PHARMACEUTICAL CO·Filed 1978·Granted Jun 3, 1980·25 cites·11 claims
- 0688US5521170ABenzamide derivatives and pharmaceutical composition comprising the sameFUJISAWA PHARMACEUTICAL CO·Filed 1994·Granted May 28, 1996·70 cites·8 claims
- 0787US4264597ACephalosporin analogues and processes for the preparation thereofHASHIMOTO MASASHI·Filed 1979·Granted Apr 28, 1981·23 cites·32 claims
- 0886US4036948AL-ascorbic acid tabletsTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1975·Granted Jul 19, 1977·53 cites·9 claims
- 0982US4666890APeptide, process for preparation thereof and use thereofFUJISAWA PHARMACEUTICAL CO·Filed 1982·Granted May 19, 1987·16 cites·24 claims
- 1081US4311640APeptide, process for preparation thereof and use thereofFUJISAWA PHARMACEUTICAL CO·Filed 1979·Granted Jan 19, 1982·21 cites·12 claims
- 1180US5187195AAnthraquinone derivatives and preparation thereofFUJISAWA PHARMACEUTICAL CO·Filed 1990·Granted Feb 16, 1993·45 cites·13 claims
- 1274US6211242B1Benzamide derivatives as vasopressin antagonistsFUJISAWA PHARMACEUTICAL CO·Filed 1995·Granted Apr 3, 2001·35 cites·8 claims
- 1373US5430022APeptide compound and its preparationFUJISAWA PHARMACEUTICAL CO·Filed 1993·Granted Jul 4, 1995·29 cites·12 claims
- 1472US4077965AAminoalkyl- or hydroxyalkyl-substituted thiadiazole derivativesFUJISAWA PHARMACEUTICAL CO·Filed 1974·Granted Mar 7, 1978·7 cites·11 claims
- 1571US6727245B2Heterobicyclic derivativesFUJISAWA PHARMACEUTICAL CO·Filed 2002·Granted Apr 27, 2004·5 cites·3 claims
- 1671US5284828APeptide compound and its preparationFUJISAWA PHARMACEUTICAL CO·Filed 1991·Granted Feb 8, 1994·33 cites·9 claims
- 1771US4172198A7-(N-substituted-2-phenylglycinamido)-3-substituted-3-cephem-4-carboxylic acid compounds and preparation thereofFUJISAWA PHARMACEUTICAL CO·Filed 1977·Granted Oct 23, 1979·5 cites·23 claims
- 1869US4801580APeptide, process for preparation thereof and use thereofFUJISAWA PHARMACEUTICAL CO·Filed 1982·Granted Jan 31, 1989·10 cites·9 claims
- 1969US4182758AHydroxyaminohydrocarbonphosphonic acid derivatives and use thereof as an antibioticFUJISAWA PHARMACEUTICAL CO·Filed 1977·Granted Jan 8, 1980·9 cites·61 claims
- 2066US4504584ACultures of novel strains of StreptomycesFUJISAWA PHARMACEUTICAL CO·Filed 1982·Granted Mar 12, 1985·9 cites·2 claims
- 2165US4921855ANew Histidyl amino acid derivatives, and pharmaceutical composition comprising the sameFUJISAWA PHARMACEUTICAL CO·Filed 1988·Granted May 1, 1990·10 cites·12 claims
- 2261US4234724ACephalosporin analogues and processes for the preparation thereofFUJISAWA PHARMACEUTICAL CO·Filed 1978·Granted Nov 18, 1980·5 cites·23 claims
- 2358US5656604APeptide compound and its preparationFUJISAWA PHARMACEUTICAL CO·Filed 1995·Granted Aug 12, 1997·9 cites·12 claims
- 2458US5296591ATrifluoromethylketone derivatives, processes for preparation thereof and use thereofFUJISAWA PHARMACEUTICAL CO·Filed 1991·Granted Mar 22, 1994·11 cites·6 claims
- 2557US5491132AAmino acid derivatives, a process for the preparation thereof and pharmaceutical composition comprising the sameFUJISAWA PHARMACEUTICAL CO·Filed 1994·Granted Feb 13, 1996·11 cites·11 claims
- 2654US6426345B1Heterobicyclic derivativesFUJISAWA PHARMACEUTICAL CO·Filed 1995·Granted Jul 30, 2002·10 cites·23 claims
- 2754US4354966APeptides, process for preparation thereof and use thereofFUJISAWA PHARMACEUTICAL CO·Filed 1980·Granted Oct 19, 1982·5 cites·9 claims
- 2853US5142048AIntermediate for preparation of amino acid derivativesFUJISAWA PHARMACEUTICAL CO·Filed 1990·Granted Aug 25, 1992·8 cites·9 claims
- 2952US4458078AOxazole derivativesFUJISAWA PHARMACEUTICAL CO·Filed 1982·Granted Jul 3, 1984·4 cites·2 claims
- 3051US5223489AAmino acid derivatives, processes for the preparation thereof and pharmaceutical composition comprising the sameUJISAWA PHARMACEUTICAL CO LTD·Filed 1992·Granted Jun 29, 1993·5 cites·10 claims
- 3150US6110933AAmino acid derivatives and their use as phospholipase A2 inhibitorFUJISAWA PHARMACEUTICAL CO·Filed 1995·Granted Aug 29, 2000·9 cites·12 claims
- 3250US2004063959A1Esters and amides as PLA2 inhibitorsFiled 2003·Application pending·0 cites
- 3349US4342760ACephalosporin analoguesFUJISAWA PHARMACEUTICAL CO·Filed 1980·Granted Aug 3, 1982·3 cites·13 claims
- 3448US4205166A7-Substituted-3-aminoalkyl-, acylaminoalkyl-, or hydroxyalkyl-substituted heterocyclic thiomethyl-3-cephem-4-carboxylic acid derivatives and preparation thereofFUJISAWA PHARMACEUTICAL CO·Filed 1975·Granted May 27, 1980·2 cites·38 claims
- 3548US2002169326A1Esters and amides as PLA2 inhibitorsFUJISAWA PHARMACEUTICAL CO·Filed 2002·Application pending·0 cites
- 3647US4324892A7-(N-Substituted-2-phenylglycinamido)-3-substituted-3-cephem-4-carboxylic acid compoundsFUJISAWA PHARMACEUTICAL CO·Filed 1979·Granted Apr 13, 1982·1 cites·5 claims
- 3746US5538950AEndothelin antagonists and their preparationFUJISAWA PHARMACEUTICAL CO·Filed 1992·Granted Jul 23, 1996·8 cites·24 claims
- 3843US4497801ANew peptides, process for preparation thereof and use thereofFUJISAWA PHARMACEUTICAL CO·Filed 1983·Granted Feb 5, 1985·5 cites·4 claims
- 3943US4472300AAzetidinone derivatives and process for preparation thereofFUJISAWA PHARMACEUTICAL CO·Filed 1980·Granted Sep 18, 1984·1 cites·1 claims
- 4039US5888972APeptide compounds, their preparation and usesFUJISAWA PHARMACEUTICAL CO·Filed 1994·Granted Mar 30, 1999·4 cites·9 claims
- 4139US4487763APeptide, process for preparation thereof and use thereofFUJISAWA PHARMACEUTICAL CO·Filed 1982·Granted Dec 11, 1984·1 cites·14 claims
- 4238US5430025AElastase-inhibiting peptides bearing a C-terminal trifluoromethylketone moietyFUJISAWA PHARMACEUTICAL CO·Filed 1993·Granted Jul 4, 1995·2 cites·6 claims
- 4336US4725582APeptide, process for preparation thereof and use thereofFUJISAWA PHARMACEUTICAL CO·Filed 1982·Granted Feb 16, 1988·1 cites·22 claims
- 4436US4476050APeptide, process for preparation thereof and use thereofFUJISAWA PHARMACEUTICAL CO·Filed 1982·Granted Oct 9, 1984·1 cites·6 claims
- 4535US4539155ANew peptide, process for preparation thereof and use thereofFUISAWA PHARMACEUTICAL COMPANY·Filed 1983·Granted Sep 3, 1985·2 cites·3 claims
- 4635US4497729APeptide, process for preparation thereof and use thereofFUJISAWA PHARMACEUTICAL CO·Filed 1981·Granted Feb 5, 1985·3 cites·9 claims
- 4735US4493794APeptide, process for preparation thereof and use thereofFUJISAWA PHARMACEUTICAL CO·Filed 1981·Granted Jan 15, 1985·3 cites·3 claims
- 4834US6207686B1Endothelin antagonistsFUJISAWA PHARMACEUTICAL CO·Filed 1995·Granted Mar 27, 2001·1 cites·11 claims
- 4934US4512980APeptide, process for preparation thereof and use thereofFUJISAWA PHARMACEUTICAL CO·Filed 1982·Granted Apr 23, 1985·2 cites·5 claims
- 5032US5057513ASpiro-thiazepine derivatives useful as paf antagonistsFUJISAWA PHARMACEUTICAL CO·Filed 1990·Granted Oct 15, 1991·1 cites·10 claims
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Keiji Hemmi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →